Elecsys Anti-HBc IgM

Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)

FDA Premarket Approval P110031 S020

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for implementation of system software 06-04 on the cobas e 602 to address a software limitation

DeviceElecsys Anti-HBc IgM
Classification NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantROCHE DIAGNOSTICS CORP.
Date Received2017-10-11
Decision Date2017-12-20
PMAP110031
SupplementS020
Product CodeLOM
Advisory CommitteeMicrobiology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address ROCHE DIAGNOSTICS CORP. 9115 Hague Road p.o. Box 50416 indianapolis, IN 46250-0457

Supplemental Filings

Supplement NumberDateSupplement Type
P110031Original Filing
S024 2018-10-26 Normal 180 Day Track No User Fee
S023 2018-10-09 30-day Notice
S022 2018-03-01 Real-time Process
S021
S020 2017-10-11 Real-time Process
S019 2017-08-03 30-day Notice
S018 2017-05-24 30-day Notice
S017 2016-12-07 Real-time Process
S016 2016-09-07 Normal 180 Day Track No User Fee
S015 2016-07-11 135 Review Track For 30-day Notice
S014 2016-02-16 30-day Notice
S013 2016-01-27 30-day Notice
S012 2016-01-27 135 Review Track For 30-day Notice
S011 2015-10-07 30-day Notice
S010 2013-07-19 Special (immediate Track)
S009
S008 2012-11-30 30-day Notice
S007
S006 2012-02-29 30-day Notice
S005 2012-02-02 30-day Notice
S004 2012-02-02 30-day Notice
S003 2012-02-02 30-day Notice
S002 2012-01-31 135 Review Track For 30-day Notice
S001 2012-01-31 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.